O'Brien Greene & Co. Inc Becton Dickinson & CO Transaction History
O'Brien Greene & Co. Inc
- $283 Million
- Q1 2025
A detailed history of O'Brien Greene & Co. Inc transactions in Becton Dickinson & CO stock. As of the latest transaction made, O'Brien Greene & Co. Inc holds 5,908 shares of BDX stock, worth $1.02 Million. This represents 0.48% of its overall portfolio holdings.
Number of Shares
5,908
Previous 5,918
0.17%
Holding current value
$1.02 Million
Previous $1.34 Million
0.82%
% of portfolio
0.48%
Previous 0.46%
Shares
27 transactions
Others Institutions Holding BDX
# of Institutions
1,806Shares Held
257MCall Options Held
3.24MPut Options Held
841K-
Vanguard Group Inc Valley Forge, PA28MShares$4.83 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY22.3MShares$3.84 Billion0.12% of portfolio
-
State Street Corp Boston, MA14MShares$2.41 Billion0.14% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD12.6MShares$2.17 Billion1.91% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.3MShares$1.95 Billion0.32% of portfolio
About BECTON DICKINSON & CO
- Ticker BDX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 285,195,008
- Market Cap $49.2B
- Description
- Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...